BR0308486A - Composição tópica compreendendo um ciclofrutano, um veìculo e uma droga - Google Patents

Composição tópica compreendendo um ciclofrutano, um veìculo e uma droga

Info

Publication number
BR0308486A
BR0308486A BR0308486-8A BR0308486A BR0308486A BR 0308486 A BR0308486 A BR 0308486A BR 0308486 A BR0308486 A BR 0308486A BR 0308486 A BR0308486 A BR 0308486A
Authority
BR
Brazil
Prior art keywords
drug
cyclofrutane
vehicle
topical composition
cyclofructan
Prior art date
Application number
BR0308486-8A
Other languages
English (en)
Inventor
Gy Rgy Lajos Kis
Christian Schoch
Dieter Lohmann
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0229019A external-priority patent/GB0229019D0/en
Priority claimed from GB0230033A external-priority patent/GB0230033D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR0308486A publication Critical patent/BR0308486A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMPOSIçãO TóPICA COMPREENDENDO UM CICLOFRUTANO, UM VEìCULO E UMA DROGA". A presente invenção refere-se em particular a um sistema de fornecimento de droga compreendendo um ciclofrutano, uma droga e um veículo polimérico.
BR0308486-8A 2002-03-18 2003-03-17 Composição tópica compreendendo um ciclofrutano, um veìculo e uma droga BR0308486A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP02006085 2002-03-18
GB0229019A GB0229019D0 (en) 2002-12-12 2002-12-12 Organic compounds
GB0230033A GB0230033D0 (en) 2002-12-23 2002-12-23 Organic compounds
PCT/EP2003/002760 WO2003077952A1 (en) 2002-03-18 2003-03-17 Topical composition comprising a cyclofructan, a carrier and a drug

Publications (1)

Publication Number Publication Date
BR0308486A true BR0308486A (pt) 2005-01-18

Family

ID=28045916

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0308486-8A BR0308486A (pt) 2002-03-18 2003-03-17 Composição tópica compreendendo um ciclofrutano, um veìculo e uma droga

Country Status (12)

Country Link
US (2) US20060216328A1 (pt)
EP (1) EP1487498B1 (pt)
JP (1) JP4523287B2 (pt)
CN (1) CN1313155C (pt)
AT (1) ATE431749T1 (pt)
AU (1) AU2003214133A1 (pt)
BR (1) BR0308486A (pt)
CA (1) CA2479351C (pt)
DE (1) DE60327693D1 (pt)
ES (1) ES2326471T3 (pt)
PT (1) PT1487498E (pt)
WO (1) WO2003077952A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8425929B2 (en) 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
US20050244463A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular vasculopathies
US8529927B2 (en) 2004-04-30 2013-09-10 Allergan, Inc. Alpha-2 agonist polymeric drug delivery systems
EP1787643A1 (en) * 2004-09-09 2007-05-23 Jimenez Bayardo, Arturo Implants and microspheres for the sustained release of drugs for ophthalmic use and preparation methods thereof
US7931909B2 (en) * 2005-05-10 2011-04-26 Allergan, Inc. Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
CA2850858A1 (en) 2005-09-16 2007-04-05 Allergan, Inc. Compositions and methods for the intraocular transport of therapeutic agents
EP2471507B1 (en) * 2006-09-29 2017-03-01 Johnson & Johnson Vision Care, Inc. Ophthalmic devices used in the treatment of ocular allergies
US20090036404A1 (en) * 2007-08-02 2009-02-05 Macleod Steven K Ophthalmic compositions comprising a carboxyl-modified fructan or a salt thereof
JP5394645B2 (ja) * 2008-03-11 2014-01-22 公益財団法人野口研究所 糖結合型スピロクラウンエーテル誘導体
US9877973B2 (en) 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US10064819B2 (en) 2008-05-12 2018-09-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
AU2009246520B2 (en) 2008-05-12 2012-04-19 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9095404B2 (en) 2008-05-12 2015-08-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9095506B2 (en) 2008-11-17 2015-08-04 Allergan, Inc. Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
EP2437684B1 (en) 2009-06-03 2022-06-15 ForSight Vision5, Inc. Anterior segment drug delivery
CN102741258B (zh) * 2009-06-17 2015-09-30 德州大学体系董事会 作为分离剂的环果聚糖的组成物及方法
DK2498783T3 (en) 2009-11-09 2018-12-10 Allergan Inc COMPOSITIONS AND PROCEDURES FOR STIMULATING HAIR GROWTH
US20110142889A1 (en) * 2009-12-16 2011-06-16 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
JP5989780B2 (ja) 2011-09-14 2016-09-07 フォーサイト・ビジョン５・インコーポレイテッドＦｏｒｓｉｇｈｔ Ｖｉｓｉｏｎ５，Ｉｎｃ． 眼挿入装置および方法
US9827250B2 (en) * 2012-07-31 2017-11-28 Johnson & Johnson Vision Care, Inc. Lens incorporating myopia control optics and muscarinic agents
RU2652063C2 (ru) 2012-10-26 2018-04-24 Форсайт Вижн5, Инк. Офтальмологическая система для замедленного высвобождения лекарственного средства в глазу
EP2956096A1 (en) 2013-02-15 2015-12-23 Allergan, Inc. Sustained drug delivery implant
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
CN106074361B (zh) * 2016-07-14 2018-10-19 何伟 一种抗眼内炎症植入剂及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1491272A (en) * 1975-09-10 1977-11-09 Lingner & Fischer Gmbh Polymer adhesive compositions containing gelling agents
JPH05310805A (ja) * 1992-05-06 1993-11-22 Mitsubishi Kasei Corp アシル化環状イヌロオリゴ糖およびその製造法
JPH06141879A (ja) * 1992-11-05 1994-05-24 Mitsubishi Kasei Corp 環状イヌロオリゴ糖の精製方法
JPH06141856A (ja) * 1992-11-05 1994-05-24 Mitsubishi Kasei Corp 環状イヌロオリゴ糖及び環状イヌロオリゴ糖生成酵素の製造方法
JPH06298807A (ja) * 1993-02-19 1994-10-25 Mitsubishi Kasei Corp 新規な環状イヌロオリゴ糖誘導体
CA2120197A1 (en) * 1993-04-02 1994-10-03 Kenji Endo Stable aqueous dispersions containing liposomes
US5464650A (en) * 1993-04-26 1995-11-07 Medtronic, Inc. Intravascular stent and method
JPH0753347A (ja) * 1993-08-19 1995-02-28 Mitsubishi Chem Corp 皮膚化粧料
JPH07274990A (ja) * 1994-04-15 1995-10-24 Mitsubishi Kasei Eng Co 環状イヌロオリゴ糖の精製方法
TW434023B (en) * 1995-09-18 2001-05-16 Novartis Ag Preserved ophthalmic composition
US5980551A (en) * 1997-02-07 1999-11-09 Endovasc Ltd., Inc. Composition and method for making a biodegradable drug delivery stent
US5972363A (en) * 1997-04-11 1999-10-26 Rohm And Haas Company Use of an encapsulated bioactive composition
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
CA2390952C (en) * 2001-07-02 2006-07-11 Rohm And Haas Company Compositions and process for retaining active ingredients comprising networked structured polymers
GB0315745D0 (en) * 2003-07-04 2003-08-13 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
DE60327693D1 (de) 2009-07-02
JP2005523299A (ja) 2005-08-04
EP1487498B1 (en) 2009-05-20
AU2003214133A1 (en) 2003-09-29
US20060216328A1 (en) 2006-09-28
CN1313155C (zh) 2007-05-02
ES2326471T3 (es) 2009-10-13
US20100160437A1 (en) 2010-06-24
ATE431749T1 (de) 2009-06-15
CA2479351A1 (en) 2003-09-25
CA2479351C (en) 2012-05-15
PT1487498E (pt) 2009-08-19
CN1642578A (zh) 2005-07-20
WO2003077952A1 (en) 2003-09-25
JP4523287B2 (ja) 2010-08-11
EP1487498A1 (en) 2004-12-22

Similar Documents

Publication Publication Date Title
BR0308486A (pt) Composição tópica compreendendo um ciclofrutano, um veìculo e uma droga
DE602004004399D1 (de) Grün gefärbte,topische pharmazeutische zusammensetzung auf der basis von metronidazol
DE60205749D1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
DK1406633T3 (da) Forbedret lægemiddeltilførsel i transdermale systemer
HU230005B1 (en) Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
AU2003228666A1 (en) Lapachone delivery systems, compositions and uses related thereto
TW200736293A (en) Conjugated polymers, the preparation and use thereof
WO2003011226A3 (en) Products and drug delivery vehicles
ATE427763T1 (de) Ballonkatheter
IL211084A0 (en) Single use module
UA85574C2 (uk) Ендопаразитоцидний засіб для місцевого застосування
TW200503640A (en) Accelerator for mineral absorption and its usage
DE60134147D1 (de) Träger in partikelform zur verbesserung der oral- absorption von wikstoffen
AU2003241469A1 (en) Personal care articles with fragrance delivery system
AU2003267581A1 (en) Drug delivery
SI1553942T1 (sl) Farmacevtski sestavek kot kombinacija tenatoprazola in proti-vnetnega agensa
NO20043646L (no) Osmotisk leveringssystem
BRPI0313645A2 (pt) composições de inalação com relações de droga elevadas.
MA27418A1 (fr) Ensemble de distribution de medicament.
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
ITMI20030972A1 (it) Indazolo dotato di attivita' analgesica, metodo per prepararlo e composizione farmaceutica che lo comprende.
TW200631589A (en) Varnish composition based on a solvent of plant origin
BRPI0410638A (pt) derivados de azitromicina
IS7538A (is) Prógestagena skammta einingar.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2308 DE 31/03/2015.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]